lansoprazole has been researched along with Hepatitis E in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ning, H | 1 |
Yu, S | 1 |
Zhu, Y | 1 |
Dong, S | 1 |
Yu, R | 1 |
Shen, S | 1 |
Niu, Z | 1 |
Li, Z | 1 |
1 other study available for lansoprazole and Hepatitis E
Article | Year |
---|---|
Genotype 3 hepatitis E has been widespread in pig farms of Shanghai suburbs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Agriculture; Animals; Animals, Domestic; China; Feces; Gene | 2008 |